Grentzinger, V., Artesi, M., Palmeira, L., Dideberg, V., Olivier, S., Bours, V., & Durkin, K. (24 April 2024). Hidden in Plain Sight: Homologous Recombination masks Filaggrin Alleles of Potential Clinical Significance [Poster presentation]. byteMAL 2024, Maastricht, Netherlands. |
Mouraux, C., FOUQUET, C., Artesi, M., Durkin, K., Dideberg, V., BULK, S., & Depierreux, F. (2024). Homozygous pathogenic MYH3 variant associated with arthrogryposis and lingual dystonia [Poster presentation]. BeSHG annual symposium 2024, Belgium. Editorial reviewed |
Apa, Z., Gilsoul, J., Dideberg, V., & Collette, F. (2024). Association between executive functions and COMT Val108/158Met polymorphism among healthy younger and older adults: A preliminary study. PLoS ONE, 19 (5), 0303343. doi:10.1371/journal.pone.0303343 Peer Reviewed verified by ORBi Dataset: https://doi.org/10.58119/ULG/DGKHVL |
Grentzinger, V., GRISART, B., Meynsbrughen, M., Artesi, M., Palmeira, L., Dideberg, V., CHARLOTEAUX, B., Durkin, K. W., Brysse, A., & Bours, V. (25 May 2023). Detecting pathogenic variants in chronic kidney disease using long-read sequencing [Paper presentation]. Annual Meeting @ Living Tomorrow Vilvoorde, Vilvoorde, Belgium. |
Gordon, D. M., Beckers, P., CASTERMANS, E., Neggers, S. J., ROSTOMYAN, L., Bours, V., Pétrossians, P., Dideberg, V., Beckers, A., & Daly, A. (01 December 2021). Dutch Founder SDHB Exon 3 Deletion in Patients with Pheochromocytoma-Paraganglioma in South Africa. Endocrine Connections, 11 (1). doi:10.1530/EC-21-0560 Peer Reviewed verified by ORBi |
Sonet, I., Palmeira, L., CHARLOTEAUX, B., CABERG, J.-H., Dideberg, V., & Bours, V. (17 September 2021). Validation of a CNV detection method on clinical-grade Exomes [Poster presentation]. 21th BeSHG meeting, Bruxelles, Belgium. |
BECKERS, P., CABERG, J.-H., DIDEBERG, V., Dangouloff, T., den Dunnen, J. T., BOURS, V., Servais, L., & BOEMER, F. (04 February 2021). Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon‑skipping therapy. Scientific Reports, 11, 3011. doi:10.1038/s41598-021-82725-z Peer Reviewed verified by ORBi |
BECKERS, P., CABERG, J.-H., DIDEBERG, V., Dangouloff, T., den Dunnen, J. T., BOURS, V., Servais, L., & BOEMER, F. (2021). Newborn Screening of Duchenne Muscular Dystrophy Specifically Targeting Deletions Amenable to Exon-skipping Therapy [Poster presentation]. European Human Genetics Conference - ESHG. |
BOEMER, F., Caberg, J.-H., Beckers, P., Dideberg, V., di Fiore, S., Bours, V., Marie, S., Dewulf, J., Marcelis, L., Deconinck, N., Daron, A., Blasco-Perez, L., Tizzano, E., Hiligsmann, M., Lombet, J., Pereira, T., Lopez-Granados, L., Shalchian-Tehran, S., van Assche, V., ... Servais, L. (2021). Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium. Scientific Reports, 11 (1), 19922. doi:10.1038/s41598-021-99496-2 Peer Reviewed verified by ORBi |
Lantoine, J., Brysse, A., DIDEBERG, V., Claes, K., Symoens, S., Coucke, W., Benoit, V., Rombout, S., De Rycke, M., Seneca, S., Van Laer, L., Wuyts, W., Corveleyn, A., Van Den Bogaert, K., Rydlewski, C., Wilkin, F., Ravoet, M., Fastré, E., Capron, A., & Vandevelde, N. M. (2021). Frequency of Participation in External Quality Assessment Programs Focused on Rare Diseases: Belgian Guidelines for Human Genetics Centers. JMIR Medical Informatics, 9 (7), 27980. doi:10.2196/27980 Peer Reviewed verified by ORBi |
PETIGNOT, S., Daly, A., CASTERMANS, E., Korpershoek, E., Scagnol, I., BECKERS, P., Dideberg, V., Rohmer, V., Bours, V., & Beckers, A. (2020). Pancreatic neuroendocrine neoplasm associated with a familial MAX deletion. Hormone and Metabolic Research. doi:10.1055/a-1186-0790 Peer Reviewed verified by ORBi |
Dangouloff, T., BOEMER, F., DIDEBERG, V., CABERG, J.-H., & Servais, L. (2020). Reader response: Discrepancy in redetermination of SMN2 copy numbers in children with SMA [letter to the editor]. Neurology. doi:10.1212/WNL.0000000000009907 Peer Reviewed verified by ORBi |
BOEMER, F., CABERG, J.-H., DIDEBERG, V., BECKERS, P., Marie, S., Marcelis, L., Bours, V., Dangouloff, T., & Servais, L. (September 2019). (S)un (M)ay (A)rise on SMA : l'espoir d'une region sans amyotrophie spinale. Revue Médicale de Liège, 74 (9), 461-464. Peer reviewed |
VALDES SOCIN, H. G., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., BOURS, V., & BECKERS, A. (2019). A novel rare case of normosmic congenital hypogonadotropic hypogonadism associating a GnRHR and a KISS1R variants. In Endocrine Abstracts - ECE 2019. |
Boemer, F., CABERG, J.-H., Dideberg, V., DARDENNE, D., Bours, V., Hiligsmann, M., Dangouloff, T., & Servais, L. (2019). Newborn screening for SMA in Southern Belgium. Neuromuscular Disorders. doi:10.1016/j.nmd.2019.02.003 Peer Reviewed verified by ORBi |
VALDES SOCIN, H. G., HARVENGT, J., Pintiaux, A., JONAS, C., PARENT, A.-S., Geenen, V., CORMAN, V., DEBRAY, F.-G., Dideberg, V., T'sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., Burlacu, C., VROONEN, L., Bours, V., ... Beckers, A. (September 2018). Etude multicentrique belge chez 56 patients avec hypogonadisme hypogonadotrope congénital (HHC) : caractérisation des anomalies génétiques et cérébrales [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France. |
VALDES SOCIN, H. G., Debray, F.-G., HARVENGT, J., LIBIOULLE, C., DIDEBERG, V., Bours, V., & Beckers, A. (September 2018). CHD7 impliqué dans l'hypogonadisme hypogonadotrope avec ou sans anosmie : description de 3 patients et de 3 nouvelles mutations [Poster presentation]. 35ème Congrès de la Société Française d'Endocrinologie, Nancy, France. |
VALDES SOCIN, H. G., LIBIOULLE, C., HARVENGT, J., PINTIAUX, A., JONAS, C., Parent, A.-S., GEENEN, V., CORMAN, V., Debray, F.-G., DIDEBERG, V., T'Sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., Bours, V., Maiter, D., & Beckers, A. (May 2018). The first Belgian series of 56 patients with congenital hypogonadotropic hypogonadism (CHH) : genetics and brain abnormalities [Poster presentation]. 20th European Congress of Endocrinology. |
VALDES SOCIN, H. G., LIBIOULLE, C., HARVENGT, J., Pintiaux, A., JONAS, C., PARENT, A.-S., GEENEN, V., CORMAN, V., Debray, F.-G., DIDEBERG, V., T'Sjoen, G., De Leerner, A., Beckers, D., Destree, A., Roland, D., Lederer, D., Boscolo, M., BOURS, V., Maiter, D., & BECKERS, A. (2018). Brain imaging and genetics in patients with congenital hypogonadotropic hypogonadism: a multicenter Belgian study. In J. O. Jorgensen, NENEG Abstract Book Communications (pp. 64). Aarhus, Denmark: Pfizer. Peer reviewed |
HARVENGT, J., LIBIOULLE, C., Debray, F.-G., DIDEBERG, V., Bours, V., & VALDES SOCIN, H. G. (16 February 2018). Brain MRI abnormalities and genetic results in a series of 30 patients with congenital isolated hypogonadotrophic hypogonadism (CIHH) [Poster presentation]. Meeting of the Belgian Society for Human Genetics (BeSHG) : "The Epigenome in development and disease", Ghent, Belgium. |
VALDES SOCIN, H. G., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., BOURS, V., & BECKERS, A. (2018). Le Syndrome de Kallmann: un vieux syndrome revisité par la génétique. Urologic, 14, 1-7. |
VALDES SOCIN, H. G., DEBRAY, F.-G., LIBIOULLE, C., DIDEBERG, V., BOURS, V., & Beckers, A. (2017). Syndrome de charge atypique avec hypogonadisme hypogonadotrope anosmique : description de 2 nouvelles mutations. In Annales d'Endocrinologie - abstract book. |
Manard, M., Bahri, M. A., Majerus, S., Phillips, C., DIDEBERG, V., Salmon, E., & Collette, F. (01 February 2017). The complex effects of COMT Val158Met polymorphism (rs4680) on working memory in healthy aging: A multivariate approach [Poster presentation]. GIGA Day. |
BOEMER, F., Fasquelle, C., D'OTREPPE DE BOUVETTE, S., JOSSE, C., DIDEBERG, V., SEGERS, K., GUISSARD, V., CAPRARO, V., Debray, F.-G., & Bours, V. (2017). A next-generation newborn screening pilot study: NGS on dried blood spots detects causal mutations in patients with inherited metabolic diseases. Scientific Reports, 7 (1), 17641. doi:10.1038/s41598-017-18038-x Peer Reviewed verified by ORBi |
VALDES SOCIN, H. G., DEBRAY, F.-G., LIBIOULLE, C., Pintiaux, A., Parent, A.-S., CORMAN, V., Gellner, K., Geenen, V., VROONEN, L., DIDEBERG, V., Bours, V., & BECKERS, A. (2016). Caractérisation clinique, neuroendocrinienne, génétique et résultats thérapeutiques dans le syndrome de Kallmann et de l'hypogonadisme normosmique idiopathique : expérience liégeoise. In Annales d'Endocrinologie : 33ème congrès de la Société Française d'Endocrinologie. |
VALDES SOCIN, H. G., CORMAN, V., LIBIOULLE, C., Debray, F.-G., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Hypogonadisme hypogonadotrope anosmique associé à une nouvelle mutation hétérozygote c.937C>T, p.His314Tyr de l'isoforme IIIb du gène FGR1. In Annales d'Endocrinologie : 33ème congrès de la Société Française d'Endocrinologie. |
Manard, M., François, S., Bahri, M. A., Phillips, C., BOURS, V., BERTOLI, S., DIDEBERG, V., Salmon, E., & Collette, F. (10 May 2016). The influence of COMT single nucleotide polymorphism (rs4680) on the neural substrates of working memory representations maintenance in healthy aging [Poster presentation]. IUAP Annual meeting. |
Potorac, I., Pintiaux, A., VALDES SOCIN, H. G., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Double genetic defect in a case of congenital hypogonadotropic hypogonadism. In Abstract book - 17th World Congress of Gynecological Endocrinology. |
Jaspar, M., Manard, M., DIDEBERG, V., Bours, V., Maquet, P., & Collette, F. (2016). Influence of COMT Genotype on Antero-Posterior Cortical Functional Connectivity Underlying Interference Resolution. Cerebral Cortex, 26, 498-509. doi:10.1093/cercor/bhu188 Peer Reviewed verified by ORBi |
VALDES SOCIN, H. G., LIBIOULLE, C., Debray, F.-G., Pintiaux, A., Parent, A.-S., CORMAN, V., Gellner, K., Geenen, V., Burlacu, C., JONAS, C., Maiter, D., T'Sjoen, G., Poppe, K., Brachet, C., DIDEBERG, V., Bours, V., & Beckers, A. (2016). Neuroendocrine phenotype, genetics and hormonal treatment outcome in idiopathic normosmic hypogonadism and Kallman syndrome patients : A multicenter Belgian Study. In Acta Clinical Belgica. |
VALDES SOCIN, H. G., Pintiaux, A., LIBIOULLE, C., DEBRAY, F.-G., DIDEBERG, V., Bours, V., & Beckers, A. (2015). Hypogonadisme hypogonadotrope normosmique familial : identification d'une nouvelle mutation c.1664-2A> T du gène FGFR1. In Abstract book - Annales d'Endocrinologie - 32ème Congrès de la Société Française d'Endocrinologie. |
DIDEBERG, V., SEGERS, K., KOOPMANSCH, B., LAMBERT, F., & Bours, V. (2015). PHARMACOGENOMIQUE ET MEDECINE PERSONNALISEE : VERS UN SCREENING SYSTEMATIQUE DE LA POPULATION ? Revue Médicale de Liège, 70 (5-6), 251-6. |
Jaspar, M., DIDEBERG, V., Bours, V., Maquet, P., & Collette, F. (2015). Modulating effect of COMT Val158Met polymorphism on interference resolution during a working memory task. Brain and Cognition, 95, 7-18. doi:10.1016/j.bandc.2015.01.013 Peer Reviewed verified by ORBi |
DEBRAY, F.-G., Stumpfig, C., Vanlander, A. V., DIDEBERG, V., Josse, C., CABERG, J.-H., BOEMER, F., Bours, V., Stevens, R., Seneca, S., Smet, J., Lill, R., & van Coster, R. (2015). Mutation of the iron-sulfur cluster assembly gene IBA57 causes fatal infantile leukodystrophy. Journal of Inherited Metabolic Disease. doi:10.1007/s10545-015-9857-1 Peer Reviewed verified by ORBi |
Jaspar, M., DIDEBERG, V., Bours, V., Salmon, E., Maquet, P., & Collette, F. (2015). Modulating effect of COMT Val158Met polymorphism on interference resolution during a working memory task [Poster presentation]. GIGA DAY 2014. |
VALDES SOCIN, H. G., Daly, A., Burlacu, C., CHAVEZ, V., CASTERMANS, E., DIDEBERG, V., HAMOIR, E., BISOGNI, C., BETEA, D., Bours, V., & Beckers, A. (2014). Le cancer thyroïdien papillaire familial (FNMTC): études cliniques et génétiques chez 8 familles. In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Française d'Endocrinologie, Lyon 5-8 novembre 2014. |
Uwineza, A., CABERG, J.-H., Hitayezu, J., JAMAR, M., DIDEBERG, V., Rusingiza, E. K., Bours, V., Mutesa, L., & Hellin, A.-C. (2014). Array-CGH analysis in Rwandan patients presenting development delay/intellectual disability with multiple congenital anomalies. BMC Medical Genetics, 15 (1), 79. doi:10.1186/1471-2350-15-79 Peer Reviewed verified by ORBi |
Jaspar, M., Genon, S., Muto, V., Meyer, C., Manard, M., DIDEBERG, V., BOURS, V., SALMON, E., Maquet, P., & Collette, F. (2014). Modulatory effect of COMT genotype on brain regions underlying proactive control process during inhibition [Poster presentation]. PAI meeting 2014. |
Jaspar, M., Genon, S., Muto, V., Meyer, C., Manard, M., DIDEBERG, V., Bours, V., Salmon, E., Maquet, P., & Collette, F. (2014). Modulating effect of COMT genotype on the brain regions underlying proactive control process during inhibition. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 50, 148-161. doi:10.1016/j.cortex.2013.06.003 Peer Reviewed verified by ORBi |
Ziegler, E., Foret, A., Mascetti, L., Muto, V., Le Bourdiec-Shaffii, A., Stender, J., Balteau, E., DIDEBERG, V., Bours, V., Maquet, P., & Phillips, C. (2013). Altered white matter architecture in BDNF Met carriers. PLoS ONE. doi:10.1371/journal.pone.0069290 Peer Reviewed verified by ORBi |
Phillips, C., Foret, A., Mascetti, L., Muto, V., Shaffi-Le Bourdiec, A., Stender, J., DIDEBERG, V., BOURS, V., Maquet, P., & Ziegler, E. (19 June 2013). Connectome-based classification of BDNF Met allele carriers [Paper presentation]. 19th Annual Meeting of the Organization for Human Brain Mapping, Seattle, United States. |
Ziegler, E., Foret, A., Mascetti, L., Muto, V., Le Bourdiec-Shaffi, A., Stender, J., Balteau, E., DIDEBERG, V., BOURS, V., Maquet, P., & Phillips, C. (June 2013). Connectome-based classification of BDNF Met allele carriers [Poster presentation]. 19th Annual Meeting of the Organization for Human Brain Mapping, Seattle, United States. |
Uwineza, A., Hitayezu, J., Murorunkwere, S., Ndinkabandi, J., Kalala Malu, C. K., CABERG, J.-H., DIDEBERG, V., BOURS, V., & Mutesa, L. (2013). Genetic diagnosis of Duchenne and Becker muscular dystrophy using multiplex ligation-dependent probe amplification in Rwandan patients. Journal of Tropical Pediatrics. doi:10.1093/tropej/fmt090 Peer Reviewed verified by ORBi |
Mascetti, L., Foret, A., Schrouff, J., Muto, V., DIDEBERG, V., Balteau, E., Degueldre, C., Phillips, C., Luxen, A., Collette, F., BOURS, V., & MAQUET, P. (2013). Concurrent Synaptic and Systems Memory Consolidation during Sleep. Journal of Neuroscience, 33 (24), 10182-10190. doi:10.1523/JNEUROSCI.0284-13.2013 Peer Reviewed verified by ORBi |
Lopez-Herrera, G., Tampella, G., Pan-Hammarstrom, Q., Herholz, P., Trujillo-Vargas, C. M., Phadwal, K., Simon, A. K., Moutschen, M., Etzioni, A., Mory, A., Srugo, I., Melamed, D., Hultenby, K., Liu, C., Baronio, M., Vitali, M., Philippet, P., DIDEBERG, V., Aghamohammadi, A., ... Grimbacher, B. (2012). Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. American Journal of Human Genetics, 90 (6), 986-1001. doi:10.1016/j.ajhg.2012.04.015 Peer Reviewed verified by ORBi |
Orlent, H., Reynaert, H., Bourgeois, S., DIDEBERG, V., Adler, M., Colle, I., De Maeght, S., Laleman, W., Michielsen, P., Moreno, C., Mulkay, J.-P., Starkel, P., & DELWAIDE, J. (2011). IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use? Acta Gastro-Enterologica Belgica, 74 (2), 317-322. Peer Reviewed verified by ORBi |
Mascetti, L., Foret, A., Matarazzo, L., Muto, V., Balteau, E., Phillips, C., Degueldre, C., Luxen, A., DIDEBERG, V., Bours, V., & Maquet, P. (15 November 2010). Influence of brain-derived neurotrophic factor val66met human polymorphism on declarative memory consolidation [Poster presentation]. Society for Neuroscience, San Diego, United States. |
Mascetti, L., Foret, A., Matarazzo, L., Muto, V., DIDEBERG, V., Bours, V., & Maquet, P. (15 September 2010). Influence of Brain-Derived Neurotrophic Factor val66met human polymorphism on declarative memory consolidation during sleep. Journal of Sleep Research, 19 (s2). Peer Reviewed verified by ORBi |
Dideberg, V., Kristjansdottir, G., Milani, L., Libioulle, C., Sigurdsson, S., Louis, E., Wiman, A. C., Vermeire, S., Rutgeerts, P., Belaiche, J., Franchimont, D., Van Gossum, A., Bours, V., & Syvanen, A. C. (15 December 2007). An insertion-deletion polymorphism in the Interferon Regulatory Factor 5 (IRF5) gene confers risk of inflammatory bowel diseases. Human Molecular Genetics, 16 (24), 3008-3016. doi:10.1093/hmg/ddm259 Peer Reviewed verified by ORBi |
Dideberg, V. (2007). Genetics and pharmacogenetics of inflammatory bowel diseases [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314934 |
Dideberg, V., Theatre, E., Farnir, F., Vermeire, S., Rutgeerts, P., De Vos, M., Belaiche, J., Franchimont, D., Van Gossum, A., Louis, E., & Bours, V. (May 2007). The TNF/ADAM 17 system: implication of an ADAM 17 haplotype in the clinical response to infliximab in Crohn's disease. European Journal of Clinical Investigation, 37 (Suppl. 1), 79. Peer Reviewed verified by ORBi |
Dideberg, V., Louis, E., & Bours, V. (2007). Pharmacogenetics of infliximab in Crohn's disease. Acta Endoscopica, 37 (4), 521-530. doi:10.1007/BF02961799 Peer reviewed |
Louis, E., Bours, V., Dideberg, V., & Belaiche, J. (2007). Les maladies inflammatoires chroniques intestinales : de la génétique au traitement. Revue Médicale de Liège, 62, 47-51. Peer reviewed |
Dideberg, V., Theatre, E., Farnir, F., Vermeire, S., Rutgeerts, P., Vos, M. D., Belaiche, J., Franchimont, D., Gossum, A. V., Louis, E., & Bours, V. (October 2006). The Tnf/Adam 17 System: Implication of an Adam 17 Haplotype in the Clinical Response to Infliximab in Crohn's Disease. Pharmacogenetics and Genomics, 16 (10), 727-734. doi:10.1097/01.fpc.0000230117.26581.a4 Peer Reviewed verified by ORBi |
Dideberg, V., Louis, E., Farnir, F., Bertoli, S., Vermeire, S., Rutgeerts, P., De Vos, M., Van Gossum, A., Belaiche, J., & Bours, V. (May 2006). Lymphotoxin alpha gene in Crohn's disease patients: absence of implication in the response to infliximab in a large cohort study. Pharmacogenetics and Genomics, 16 (5), 369-373. doi:10.1097/01.fpc.0000204993.91806.b1 Peer Reviewed verified by ORBi |
Dideberg, V., & Bours, V. (December 2005). Integration de la pharmacogenetique dans la pratique medicale. Revue Médicale de Liège, 60 (12), 918-22. Peer reviewed |
Verloes, A., JAMAR, M., Dideberg, V., & Herens, C. (2001). Episphalosomic Syndrome : A Mca Syndrome Ressembling Fanconi Anemia, with Increased Baseline Level of Chromosome Breaks but No Hypersensivity to Clastogens. Annales de Génétique, 44 (2, Apr-Jun), 59-62. doi:10.1016/S0003-3995(01)01043-7 Peer Reviewed verified by ORBi |
Verloes, A., Gillerot, Y., Van Maldergem, L., Schoos, R., Herens, C., Jamar, M., Dideberg, V., Lesenfants, S., & Koulischer, L. (January 2001). Major Decrease in the Incidence of Trisomy 21 at Birth in South Belgium: Mass Impact of Triple Test? European Journal of Human Genetics, 9 (1), 1-4. doi:10.1038/sj.ejhg.5200575 Peer Reviewed verified by ORBi |